Happy Holidays & Happy New Year from the EMDB team! During this period (23rd December - 6th January) the EMDB team and our OneDep curators will be working at reduced capacity. We will continue to run the weekly release of entries as normal, but entry annotation & support may be slower than usual. Thanks for your understanding.
EMD-21653
Cryo-EM Structure of Hepatitis B virus T=4 capsid in complex with the antiviral molecule DBT1
EMD-21653
Single-particle4.6 Å
Deposition: 03/04/2020
Map released: 03/06/2020
Last modified: 06/03/2024
Sample Organism:
Hepatitis B virus genotype D subtype adw
Sample: Hepatitis B virus genotype D subtype adw
Fitted models: 6wfs (Avg. Q-score: 0.244)
Deposition Authors: Schlicksup C, Laughlin P
Sample: Hepatitis B virus genotype D subtype adw
Fitted models: 6wfs (Avg. Q-score: 0.244)
Deposition Authors: Schlicksup C, Laughlin P
Local Stabilization of Subunit-Subunit Contacts Causes Global Destabilization of Hepatitis B Virus Capsids.
Schlicksup CJ,
Laughlin P ,
Dunkelbarger S,
Wang JC ,
Zlotnick A
(2020) ACS Chem Biol , 15 , 1708 - 1717
(2020) ACS Chem Biol , 15 , 1708 - 1717
Abstract:
Development of antiviral molecules that bind virion is a strategy that remains in its infancy, and the details of their mechanisms are poorly understood. Here we investigate the behavior of DBT1, a dibenzothiazepine that specifically interacts with the capsid protein of hepatitis B virus (HBV). We found that DBT1 stabilizes protein-protein interaction, accelerates capsid assembly, and can induce formation of aberrant particles. Paradoxically, DBT1 can cause preformed capsids to dissociate. These activities may lead to (i) assembly of empty and defective capsids, inhibiting formation of new virus, and (ii) disruption of mature viruses, which are metastable, to inhibit new infection. Using cryo-electron microscopy, we observed that DBT1 led to asymmetric capsids where well-defined DBT1 density was bound at all intersubunit contacts. These results suggest that DBT1 can support assembly by increasing buried surface area but induce disassembly of metastable capsids by favoring asymmetry to induce structural defects.
Development of antiviral molecules that bind virion is a strategy that remains in its infancy, and the details of their mechanisms are poorly understood. Here we investigate the behavior of DBT1, a dibenzothiazepine that specifically interacts with the capsid protein of hepatitis B virus (HBV). We found that DBT1 stabilizes protein-protein interaction, accelerates capsid assembly, and can induce formation of aberrant particles. Paradoxically, DBT1 can cause preformed capsids to dissociate. These activities may lead to (i) assembly of empty and defective capsids, inhibiting formation of new virus, and (ii) disruption of mature viruses, which are metastable, to inhibit new infection. Using cryo-electron microscopy, we observed that DBT1 led to asymmetric capsids where well-defined DBT1 density was bound at all intersubunit contacts. These results suggest that DBT1 can support assembly by increasing buried surface area but induce disassembly of metastable capsids by favoring asymmetry to induce structural defects.